B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

OTUD3

MOLECULAR TARGET

OTU deubiquitinase 3

UniProt: Q5T2D3NCBI Gene: 232526 compounds

OTUD3 (OTU deubiquitinase 3) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting OTUD3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
2Quercetin0.691
3alpha-Linolenic Acid0.691
4salvin [Supplementary Concept]0.691
5carnosol0.691
6piceatannol0.691

About OTUD3 as a Drug Target

OTUD3 (OTU deubiquitinase 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented OTUD3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

OTUD3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.